VOGLITAB M 0.2MG (Metformin (500mg) + Voglibose (0.2mg))

Voglitab-M 0.2 mg is classified among anti-diabetic medications and is primarily utilized in the management of type 2 diabetes mellitus in adult patients. This medication is formulated as a combination of various active ingredients, which work collaboratively to assist individuals in regulating their blood glucose levels effectively. It is important to take Voglitab-M 0.2 mg with food to enhance its absorption and minimize potential gastrointestinal discomfort. Consistency in taking this medication at the same time each day is vital for optimal results. Dosage adjustments may be necessary based on individual response and blood sugar readings, as determined by your healthcare provider. Continuing this medication is crucial even if you feel well or your blood sugar seems stable, as discontinuation without medical advice could lead to rising glucose levels, which may increase the risk of complications such as kidney damage, vision impairment, nerve issues, and potential limb loss. This treatment is most effective when combined with a well-balanced diet, regular physical activity, and weight management, as recommended by your doctor. Common side effects may include nausea, altered taste sensation, reduced appetite, excessive gas, abdominal discomfort, diarrhea, and skin rashes. These effects are often transient but should be monitored. If they persist or cause significant concern, it is advisable to consult your healthcare provider, who may provide strategies to alleviate these issues. Certain contraindications exist, including type 1 diabetes, diabetic ketoacidosis, and severe liver or kidney diseases, necessitating a thorough discussion with your healthcare provider regarding your medical history.